The results are consistent with ST6Gal-I being a potential biomarker of carcinoma progression.25, 26 In HCC and normal liver cell lines, ST6Gal-I was expressed in all tested cells as indicated by qPCR and western blot assays. This evidence concerns the gene ST6GAL1 and hepatocellular carcinoma.